Revvity, Inc.
$166.85
+1.52 · +0.92% today
Market open · updated 12:45:29 PM ET
- High
- $168.44 10:20 AM
- Low
- $158.01 6:35 AM
Against the S&P 500 Price change through Oct 27, 2026
RVTY+67.30%
S&P 500+12.87%
RVTY+66.59%
S&P 500+12.32%
RVTY+65.38%
S&P 500+87.41%
RVTY−6.86%
S&P 500+69.55%
Key numbers
- Previous close
- $165.33
- Open
- $165.32
- Day's range
- $163.05 – $167.16
- 52-week range
- $81.22 – $169.06
- Volume
- 641,184
- Average volume
- 1.7 million
- Market value
- $18.6 billion
- Price to earnings
- 76.4last 12 months
- Earnings per share
- $2.13last 12 months
- Beta
- 1.06moves about as much as the market
- Dividend
- $0.28 a year · 0.17%
- 50-day average
- $142.90
- 200-day average
- $111.38
Tuesday, Nov 3, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who Revvity competes with From our value chain
Revvity in the news
No desk stories on RVTY yet. When we write about it, the story leads this list.
- HeadlineWill Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research · October 27, 2026 at 1:11 PM ET
- HeadlineRevvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research · October 27, 2026 at 11:06 AM ET
- HeadlineELV vs. RVTY: Which Stock Is the Better Value Option?Zacks Investment Research · October 23, 2026 at 12:40 PM ET
- HeadlineRevvity Launches Signals LabGistics to Coordinate Scientific WorkflowsZacks Investment Research · October 22, 2026 at 11:35 AM ET
- HeadlineRevvity: A Diagnostics Annuity Is Quietly Funding An AI Data EngineSeeking Alpha · October 22, 2026 at 9:04 AM ET
- CongressGilbert Cisneros sold $15,001 - $50,000 of RVTYHouse filing · disclosed Oct 12, 2026
- CongressGilbert Cisneros sold $1,001 - $15,000 of RVTYHouse filing · disclosed Oct 12, 2026
- CongressGilbert Cisneros sold $1,001 - $15,000 of RVTYHouse filing · disclosed Oct 12, 2026
Earnings
Next report: Tuesday, Nov 3, 2026, before the open.
Congress trades in RVTY
4 purchases and 4 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Gilbert CisnerosHouse · D-California | Sale | $15,001 - $50,000 | Sep 9, 2026 | Oct 12, 2026 |
| Gilbert CisnerosHouse · D-California | Sale | $1,001 - $15,000 | Sep 4, 2026 | Oct 12, 2026 |
| Gilbert CisnerosHouse · D-California | Sale | $1,001 - $15,000 | Sep 3, 2026 | Oct 12, 2026 |
| Gilbert CisnerosHouse · D-California | Purchase | $15,001 - $50,000 | May 4, 2026 | Jun 9, 2026 |
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Sep 12, 2025 | Oct 13, 2025 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 29, 2025 | Oct 3, 2025 |
| Ro KhannaHouse · D-California | Sale | $1,000 - $15,000 | Aug 26, 2025 | Sep 12, 2025 |
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Aug 13, 2025 | Sep 12, 2025 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Revvity
Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 11,000
- Headquarters
- Waltham, Massachusetts
- Website
- revvity.com
- Listed
- Jul 6, 1965
More medical - diagnostics & research stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.